About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

FDA Approves Nevro’s Senza Spinal Cord Stimulation System Delivering HF10 Therapy

by Vishnuprasad on May 12, 2015 at 10:02 PM
Font : A-A+

FDA Approves Nevro’s Senza Spinal Cord Stimulation System Delivering HF10 Therapy

The United States Food and Drug Administration (FDA) has approved Nevro's Senza spinal cord stimulation (SCS) system.

The Senza SCS system, which delivers Nevro's proprietary HF10 therapy, can aid in the management of chronic intractable pain of the trunk and limbs. The chronic intractable pain includes unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain and leg pain.

Advertisement

The Senza system has experienced strong adoption in Europe and Australia over the past 5 years. With the approval, patients in the US suffering from chronic pain will have the opportunity to experience the significant benefits of HF10 therapy.

The Senza system was the subject of the SENZA-RCT pivotal study. The ground-breaking study was the first to directly compare SCS therapies. The multicenter compared the safety and effectiveness of HF10 therapy to traditional SCS therapy.
Advertisement

"My fellow investigators and I have eagerly awaited the approval of the Senza SCS system. The results of the study showed that HF10 therapy provides better pain relief and nearly twice the response rate of traditional SCS, representing a tangible advance in chronic pain management. HF10 therapy will allow me to help more patients in my practice by addressing back pain in addition to leg pain," said Dr. Leonardo Kapural, lead investigator for the SENZA-RCT pivotal study from Wake Forest University Baptist Medical Center.



Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Ways to Manage Stress during COVID-19 Pandemic
Can Adjusting Fatty Acid Intake Improve Mood in Bipolar Disorder Patients?
Insulin Resistance Doubles the Risk of Major Depressive Disorder
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Reiki and Pranic Healing Back Pain at Workplace: Prevention and Exercises Discectomy 

Recommended Reading
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as ......
Maharashtra FDA Files FIR Against E-commerce Site for Online Sale of Abortion Kit
When officials raided the office of shopclues.com, they found abortion kits that are supposed to be ...
FDA Clears Medtronic’s Euphora Semicompliant Balloon Dilatation Catheter
The catheter helps physicians determine lesion characteristics, stent selection and also ......
FDA Approves World’s Smallest MR-Conditional Spinal Cord Stimulation System
Protege MRI spinal cord stimulator is also an upgradeable MR-conditional device that can be safely ....
Back Pain at Workplace: Prevention and Exercises
Understanding the basics about our back and our posture is very important in preventing back pain an...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use